A detailed history of Crestwood Advisors Group LLC transactions in Amgen Inc stock. As of the latest transaction made, Crestwood Advisors Group LLC holds 10,460 shares of AMGN stock, worth $3.34 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
10,460
Previous 9,148 14.34%
Holding current value
$3.34 Million
Previous $2.6 Million 25.69%
% of portfolio
0.07%
Previous 0.06%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024

BUY
$262.75 - $319.31 $344,728 - $418,934
1,312 Added 14.34%
10,460 $3.27 Million
Q1 2024

May 08, 2024

BUY
$268.87 - $324.56 $36,566 - $44,140
136 Added 1.51%
9,148 $2.6 Million
Q4 2023

Jan 29, 2024

BUY
$255.7 - $288.46 $20,967 - $23,653
82 Added 0.92%
9,012 $2.6 Million
Q3 2023

Nov 15, 2023

BUY
$218.65 - $271.46 $273,968 - $340,139
1,253 Added 16.32%
8,930 $2.4 Million
Q2 2023

Aug 15, 2023

BUY
$214.27 - $253.37 $260,766 - $308,351
1,217 Added 18.84%
7,677 $1.7 Million
Q1 2023

May 12, 2023

BUY
$225.79 - $275.2 $450,451 - $549,024
1,995 Added 44.68%
6,460 $1.56 Million
Q4 2022

Feb 14, 2023

BUY
$229.03 - $291.01 $14,657 - $18,624
64 Added 1.45%
4,465 $1.17 Million
Q3 2022

Oct 26, 2022

BUY
$224.46 - $253.15 $32,322 - $36,453
144 Added 3.38%
4,401 $992,000
Q2 2022

Jul 07, 2022

BUY
$230.71 - $256.74 $46,372 - $51,604
201 Added 4.96%
4,257 $1.04 Million
Q1 2022

Apr 12, 2022

BUY
$219.27 - $242.57 $24,338 - $26,925
111 Added 2.81%
4,056 $981,000
Q4 2021

Feb 15, 2022

BUY
$198.88 - $227.6 $24,064 - $27,539
121 Added 3.16%
3,945 $888,000
Q3 2021

Nov 03, 2021

SELL
$212.27 - $248.7 $31,203 - $36,558
-147 Reduced 3.7%
3,824 $813,000
Q2 2021

Aug 13, 2021

SELL
$233.58 - $259.14 $31,299 - $34,724
-134 Reduced 3.26%
3,971 $968,000
Q1 2021

Apr 21, 2021

SELL
$221.91 - $258.6 $133,367 - $155,418
-601 Reduced 12.77%
4,105 $1.02 Million
Q4 2020

Feb 09, 2021

BUY
$216.38 - $257.67 $13,415 - $15,975
62 Added 1.34%
4,706 $1.08 Million
Q3 2020

Oct 06, 2020

SELL
$234.65 - $260.95 $12,905 - $14,352
-55 Reduced 1.17%
4,644 $1.18 Million
Q2 2020

Aug 14, 2020

BUY
$197.81 - $242.74 $9,297 - $11,408
47 Added 1.01%
4,699 $1.11 Million
Q1 2020

May 15, 2020

BUY
$182.24 - $241.7 $17,312 - $22,961
95 Added 2.08%
4,652 $943,000
Q4 2019

Feb 12, 2020

SELL
$189.21 - $243.2 $30,273 - $38,912
-160 Reduced 3.39%
4,557 $1.1 Million
Q3 2019

Nov 13, 2019

SELL
$174.11 - $208.62 $60,067 - $71,973
-345 Reduced 6.82%
4,717 $913,000
Q2 2019

Aug 14, 2019

BUY
$166.7 - $195.41 $257,718 - $302,103
1,546 Added 43.97%
5,062 $933,000
Q1 2019

May 09, 2019

BUY
$180.87 - $203.88 $35,088 - $39,552
194 Added 5.84%
3,516 $668,000
Q4 2018

Feb 14, 2019

BUY
$178.4 - $208.25 $37,107 - $43,316
208 Added 6.68%
3,322 $647,000
Q3 2018

Nov 15, 2018

SELL
$185.29 - $208.89 $5,373 - $6,057
-29 Reduced 0.92%
3,114 $646,000
Q2 2018

Aug 14, 2018

SELL
$166.05 - $186.51 $12,453 - $13,988
-75 Reduced 2.33%
3,143 $0
Q1 2018

May 14, 2018

SELL
$169.43 - $198.0 $59,808 - $69,894
-353 Reduced 9.89%
3,218 $549,000
Q4 2017

Jan 11, 2018

BUY
$168.79 - $188.59 $58,063 - $64,874
344 Added 10.66%
3,571 $621,000
Q3 2017

Nov 20, 2017

BUY
$167.29 - $191.0 $539,844 - $616,357
3,227
3,227 $602,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Crestwood Advisors Group LLC Portfolio

Follow Crestwood Advisors Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crestwood Advisors Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crestwood Advisors Group LLC with notifications on news.